Myocardial protection after systemic application of L-arginine during reperfusion

Journal of Cardiovascular Pharmacology

Volumn 43, Issue 6, 2004, Pages 782-788

  Soós, Pál ^a,b,c   Andrási, Terézia ^a   Buhmann, Volker ^a   Kohl, Brigitte ^a   Vahl, Christian ^a   Hagl, Siegfried ^a   Szabó, Gábor ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c Labor of Cardiac Surgery   (Germany)

Author keywords

Cardiac surgery; Cardioplegia; Ischemia; L arginine; Nitric oxide; Reperfusion

Indexed keywords

ACETYLCHOLINE; ARGININE; NITRIC OXIDE; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL GAS; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; HEART ARREST; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE WORK; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PRELOAD; HEART PROTECTION; HYPOTHERMIA; LUNG FUNCTION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; ARGININE; DOGS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRIC OXIDE;

EID: 2542421863     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200406000-00007     Document Type: Article

References (38)

1. Wallace A, Lam HW, Nose PS, et al. Changes in systolic and diastolic ventricular function with cold cardioplegic arrest in man. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group. J Card Surg. 1994;9:497-502.
2. Lewis ME, Al Khalidi AH, Townend JN, et al. The effects of hypothermia on human left ventricular contractile function during cardiac surgery. J Am Coll Cardiol. 2002;39:102-108.
3. Nakamura T, Vollmar B, Winning J, et al. Heparin and the nonanticoagulant N-acetyl heparin attenuate capillary no-reflow after normothermic ischemia of the lung. Ann Thorac Surg. 2001;72:1183-1188.
4. Gomes WJ, Erlichman MR, Batista-Filho ML, et al. Vasoplegic syndrome after off-pump coronary artery bypass surgery. Eur J Cardiothorac Surg. 2003;23:165-169.
5. Rothenburger M, Soeparwata R, Deng MC, et al. Prediction of clinical outcome after cardiac surgery: the role of cytokines, endotoxin, and anti-endotoxin core antibodies. Shock. 2001;16(Suppl 1):44-50.
6. Morse DS, Adams D, Magnani B. Platelet and neutrophil activation during cardiac surgical procedures: impact of cardiopulmonary bypass. Ann Thorac Surg. 1998;65:691-695.
7. Andrasi TB, Buhmann V, Soos P, et al. Mesenteric complications after hypothermic cardiopulmonary bypass with cardiac arrest: underlying mechanisms. Artif Organs. 2002;26:943-946.
8. Boger RH, Bode-Boger SM. The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol. 2001;41:79-99.
9. Gewaltig MT, Kojda G. Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc Res. 2002;55:250-260.
10. Vallance P, Chan N. Endothelial function and nitric oxide: clinical relevance. Heart. 2001;85:342-350.
11. Pabla R, Buda AJ, Flynn DM, et al. Intracoronary nitric oxide improves postischemic coronary blood flow and myocardial contractile function. Am J Physiol. 1995;269:H1113-H1121.
12. Szabo G, Bahrle S, Batkai S, et al. L-arginine: effect on reperfusion injury after heart transplantation. World J Surg. 1998;22:791-797.
13. Wolin MS. Interactions of oxidants with vascular signaling systems. Arterioscler Thromb Vase Biol. 2000;20:1430-1442.
14. Schulz R, Wambolt R. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury. Cardiovasc Res. 1995;30:432-439.
15. Maczewski M, Beresewicz A. Role of nitric oxide and free radicals in cardioprotection by blocking Na+/H+ and Na+/Ca2+ exchange in rat heart. Eur J Pharmacol. 2003;461:139-147.
16. Kronon MT, Allen BS, Halldorsson A, et al. Dose dependency of L-arginine in neonatal myocardial protection: the nitric oxide paradox. J Thorac Cardiovasc Surg. 1999;118:655-664.
17. Amrani M, Gray CC, Smolenski RT, et al. The effect of L-arginine on myocardial recovery after cardioplegic arrest and ischemia under moderate and deep hypothermia. Circulation. 1997;96:274-279.
18. Meyer J, Richter N, Hecker M. High-performance liquid chromatographic determination of nitric oxide synthase-related arginine derivatives in vitro and in vivo. Anal Biochem. 1997;247:11-16.
19. Mendes Ribeiro AC, Brunini TM, Ellory JC, et al. Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure. Cardiovasc Res. 2001;49:697-712.
20. Cooke JP, Andon NA, Girerd XJ, et al. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation. 1991;83:1057-1062.
21. Szabo G, Batkai S, Bahrle S, et al. Effects of nitric oxide synthesis on reperfusion injury and catecholamine responsiveness in a heterotopic rat heart-transplantation model. J Cardiovasc Pharmacol. 1998;31:221-230.
22. Suematsu Y, Ohtsuka T, Hirata Y, et al. L-Arginine given after ischaemic preconditioning can enhance cardioprotection in isolated rat hearts. Eur J Cardiothorac Surg. 2001;19:873-879.
23. Angdin M, Settergren G, Liska J, et al. No effect of L-arginine supplementation on pulmonary endothelial dysfunction after cardiopulmonary bypass. Acta Anaesthesiol Scand. 2001;45:441-448.
24. Wang QD, Morcos E, Wiklund P, et al. L-arginine enhances functional recovery and Ca(2+)-dependent nitric oxide synthase activity after ischemia and reperfusion in the rat heart. J Cardiovasc Pharmacol. 1997;29:291-296.
25. Hatsuoka S, Sakamoto T, Stock UA, et al. Effect of L-arginine or nitroglycerine during deep hypothermic circulatory arrest in neonatal lambs. Ann Thorac Surg. 2003;75:197-203.
26. Pabla R, Buda AJ, Flynn DM, et al. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. Circ Res. 1996;78:65-72.
27. Ferdinandy P, Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol. 2003;138:532-543.
28. Cohen G, Borger MA, Weisel RD, et al. Intraoperative myocardial protection: current trends and future perspectives. Ann Thorac Surg. 1999;68:1995-2001.
29. Hayashida N, Tomoeda H, Oda T, et al. Effects of supplemental L-arginine during warm blood cardioplegia. Ann Thorac Cardiovasc Surg. 2000;6:27-33.
30. Mizuno A, Baretti R, Buckberg GD, et al. Endothelial stunning and myocyte recovery after reperfusion of jeopardized muscle: a role of L-arginine blood cardioplegia. J Thorac Cardiovasc Surg. 1997;113:379-389.
31. Jiang Z, Kejian H, Lei CY, et al. Effects of L-arginine cardioplegia on myocardium. J Extra Corpor Technol. 2001;33:10-14.
32. Carrier M, Pellerin M, Perrault LP, et al. Cardioplegic arrest with L-arginine improves myocardial protection: results of a prospective randomized clinical trial. Ann Thorac Surg. 2002;73:837-841.
33. Bode-Boger SM, Boger RH, Creutzig A, et al. L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin. Sci. (Lond). 1994;87:303-310.
34. Tangphao O, Grossmann M, Chalon S, et al. Pharmacokinetics of intravenous and oral L-arginine in normal volunteers. Br J Clin Pharmacol. 1999;47:261-266.
35. Kelm M. Nitric oxide metabolism and breakdown. Biochim Biophys Acta. 1999;1411:273-289.
36. Brunner F, Maier R, Andrew P, et al. Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Cardiovasc Res. 2003;57:55-62.
37. Demers P, Elkouri S, Sirois MG, et al. Effects of acute rejection on L-arginine/iNOS pathway in canine heart transplantation. Can J Cardiol. 2003;19:419-425.
38. Andrasi TB, Soos P, Bakos G, et al. L-arginine protects the mesenteric vascular circulation against cardiopulmonary bypass-induced vascular dysfunction. Surgery. 2003;134:72-79.